D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 61,000
-3,300 (-5.13%)
Jul 21, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 2.95 trillion as of July 20, 2026. Its market cap has increased by 76.76% in one year.
Market Cap
2.95T
Enterprise Value
2.93T
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
61,000.00
ChartMarket Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 2.95T, an increase of 676.52%. That is a compound annual growth rate of 152.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 2.95T | -26.25% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 9.85T |
| SK Biopharmaceuticals | 6.22T |
| Kolon TissueGene | 5.28T |
| HLB Co., Ltd. | 4.69T |
| LigaChem Biosciences | 3.82T |
| OliX Pharmaceuticals | 2.87T |
| SK bioscience | 2.78T |
| Peptron | 2.78T |